Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice
- 1 January 1985
- journal article
- research article
- Published by Wiley in Biology of the Cell
- Vol. 53 (1) , 33-36
- https://doi.org/10.1111/j.1768-322x.1985.tb00352.x
Abstract
The depletion of polyamines by .alpha.-difluoromethylornithine (DFMO) treatment of mice after s.c. inoculation of adenocarcinoma M3 cells caused a remarkable inhibition in the growth rate of primary tumors as well as in the occurrence and number of lung metastases with a concomitant increase in survival time. Tumor-bearing mice submitted to the surgical removal of primary tumors and then treated with .alpha.-difluoromethylornithine also showed a significant reduction of lung metastases. A lower number of lung metastatic nodules correlated with decreased levels of polyamines in the same tissue. The described approach provides a useful experimental model for studies in human cancer therapy.This publication has 3 references indexed in Scilit:
- SUCCESSFUL TREATMENT WITH DL-ALPHA-DIFLUOROMETHYLORNITHINE IN ESTABLISHED HUMAN SMALL CELL VARIANT LUNG-CARCINOMA IMPLANTS IN ATHYMIC MICE1983
- Polyamines are necessary for the survival of human small-cell lung carcinoma in culture.Proceedings of the National Academy of Sciences, 1981
- Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis ; Effects of α-difluoromethyl- ornithine, an irreversible inhibitor or ornithine decarboxylaseLife Sciences, 1980